NASDAQ:VERO Venus Concept (VERO) Stock Price, News & Analysis $2.21 -0.10 (-4.33%) As of 08/29/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Venus Concept Stock (NASDAQ:VERO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Venus Concept alerts:Sign Up Key Stats Today's Range$2.20▼$2.3050-Day Range$2.18▼$2.9552-Week Range$2.10▼$14.50Volume38,971 shsAverage Volume41,378 shsMarket Capitalization$3.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. Read More Venus Concept Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreVERO MarketRank™: Venus Concept scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Venus Concept. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Venus Concept is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Venus Concept is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVenus Concept has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Venus Concept's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.01% of the float of Venus Concept has been sold short.Short Interest Ratio / Days to CoverVenus Concept has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Venus Concept has recently increased by 21.25%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVenus Concept does not currently pay a dividend.Dividend GrowthVenus Concept does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.01% of the float of Venus Concept has been sold short.Short Interest Ratio / Days to CoverVenus Concept has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Venus Concept has recently increased by 21.25%, indicating that investor sentiment is decreasing significantly. News and Social Media1.5 / 5News SentimentN/A News SentimentVenus Concept has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.05 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Venus Concept this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for VERO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Venus Concept insiders have not sold or bought any company stock.Percentage Held by Insiders28.04% of the stock of Venus Concept is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.41% of the stock of Venus Concept is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Venus Concept's insider trading history. Receive VERO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VERO Stock News HeadlinesAnalysts Conflicted on These Healthcare Names: Venus Concept (VERO) and TuHURA Biosciences (HURA)August 22, 2025 | theglobeandmail.comVenus Concept Inc. (NASDAQ:VERO) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do… | Brownstone Research (Ad)Venus Concept Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comVenus Concept Inc. (VERO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comVenus Concept Amends Loan Agreements for Financial ReliefAugust 14, 2025 | theglobeandmail.comVenus Concept Announces Second Quarter 2025 Financial ResultsAugust 14, 2025 | globenewswire.comVenus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025July 16, 2025 | globenewswire.comSee More Headlines VERO Stock Analysis - Frequently Asked Questions How have VERO shares performed this year? Venus Concept's stock was trading at $4.1415 at the start of the year. Since then, VERO stock has decreased by 46.6% and is now trading at $2.21. How were Venus Concept's earnings last quarter? Venus Concept Inc. (NASDAQ:VERO) announced its quarterly earnings results on Thursday, August, 14th. The company reported ($8.03) EPS for the quarter, beating the consensus estimate of ($9.72) by $1.69. The company had revenue of $15.69 million for the quarter, compared to analyst estimates of $14.01 million. Venus Concept had a negative net margin of 68.77% and a negative trailing twelve-month return on equity of 871.77%. Read the conference call transcript. When did Venus Concept's stock split? Venus Concept's stock reverse split before market open on Tuesday, March 4th 2025.The 1-11 reverse split was announced on Friday, February 14th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 3rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. How do I buy shares of Venus Concept? Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Venus Concept own? Based on aggregate information from My MarketBeat watchlists, some other companies that Venus Concept investors own include Tesla (TSLA), Agenus (AGEN), Cisco Systems (CSCO), Taiwan Semiconductor Manufacturing (TSM), Intel (INTC), Pfizer (PFE) and Company Calendar Last Earnings8/14/2025Today8/29/2025Next Earnings (Estimated)11/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:VERO CIK1409269 Webwww.venusconcept.com Phone(888) 907-0115FaxN/AEmployees410Year FoundedN/AProfitability EPS (Trailing Twelve Months)($50.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$47 million Net Margins-68.77% Pretax Margin-69.32% Return on Equity-871.77% Return on Assets-61.92% Debt Debt-to-Equity Ratio5.72 Current Ratio1.10 Quick Ratio0.71 Sales & Book Value Annual Sales$64.83 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book1.13Miscellaneous Outstanding Shares1,420,000Free Float1,025,000Market Cap$3.14 million OptionableNot Optionable Beta0.12 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:VERO) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.